Portal de Periódicos da CAPES

Autosomal Dominant Growth Hormone (GH) Deficiency Type II: The Del32–71-GH Deletion Mutant Suppresses Secretion of Wild-Type GH 1

2000; Oxford University Press; Volume: 141; Issue: 3 Linguagem: Inglês

10.1210/endo.141.3.7380

1945-7170

Min S. Lee, Michael P. Wajnrajch, Steve Kim, Leslie Plotnick, Julie Wang, Joseph M. Gertner, Rudolph L. Leibel, Priscilla S. Dannies,

RNA modifications and cancer

Familial isolated GH deficiency type II is an autosomal dominant form of short stature, associated in some families with mutations that result in missplicing to produce del32–71-GH, a protein that cannot fold normally. The mechanism by which this mutant suppresses the secretion of wild-type GH encoded by the normal allele is not known. Coexpression of del32–71-GH with wild-type human GH in transient transfections of the neuroendocrine cell lines GH4C1 and AtT20 suppressed accumulation of wild-type GH. The suppression of wild-type GH accumulation by del32–71-GH was a posttranslational effect on wild-type GH caused by decreased stability, rather than decreased synthesis, of wild-type GH. Coexpression of del32–71-GH with human PRL did not suppress accumulation of PRL, indicating that there was not a general suppression of secretory pathway function. Accumulation of del32–71-GH protein was not necessary for the suppression of wild-type GH, because del32–71-GH did not accumulate in the neuroendocrine cell lines in which suppression of accumulation of wild-type GH was observed. Del32–71-GH did accumulate in transfected COS and CHO cells, but did not suppress the accumulation of wild-type GH in these cells. These studies suggest that del32–71-GH may cause GH deficiency in somatotropes of heterozygotes expressing both wild-type and del32–71-GH by decreasing the intracellular stability of wild-type GH.